Shots: Nurix to receive $45M upfront, up to $2.3B as milestones and royalties on sales, and will identify novel targets, utilizing its discovery platform & E3 ligases inducing degradation of […]readmore
Tags : Protein Degradation Therapies
Shots: Kymera to receive $70M upfront including equity investment, >$1B as development, regulatory & commercial milestones for up to 6 therapies opted by Vertex, royalties on sales of products and […]readmore